Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
qgN2g7uC0EkzeGnx
